RKLB: 8% | Rocket Lab shares are trading higher after the company reported better-than-expected Q1 sales results and issued Q2 sales guidance above estimates. The company announced it will acquire Motiv Space Systems and was awarded a $30 million contract by Anduril Industries for multiple hypersonic test flights.

COIN: -5% | Coinbase Global shares are trading lower after the company reported worse-than-expected Q1 financial results.

ARTV: 25% | Artiva Reports 71% ACR50 Response In Refractory RA Patients Treated With AlloNK, Plans Phase 3 Registrational Trial In 2026 Following FDA Alignment. Also, Artiva Biotherapeutics Prices $300 M Offering Of Common Stock And Pre-Funded Warrants At $11.52 Per Share